11-77155908-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_000260.4(MYO7A):c.287C>T(p.Thr96Met) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000113 in 1,596,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/23 in silico tools predict a damaging outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T96T) has been classified as Benign.
Frequency
Consequence
NM_000260.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.287C>T | p.Thr96Met | missense_variant, splice_region_variant | 5/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.287C>T | p.Thr96Met | missense_variant, splice_region_variant | 5/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.287C>T | p.Thr96Met | missense_variant, splice_region_variant | 5/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.254C>T | p.Thr85Met | missense_variant, splice_region_variant | 6/50 | 1 | ENSP00000386635.2 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152246Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000130 AC: 3AN: 230894Hom.: 0 AF XY: 0.0000240 AC XY: 3AN XY: 124768
GnomAD4 exome AF: 0.00000554 AC: 8AN: 1444528Hom.: 0 Cov.: 31 AF XY: 0.00000559 AC XY: 4AN XY: 716076
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152246Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74386
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | May 27, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2022 | This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 96 of the MYO7A protein (p.Thr96Met). This variant is present in population databases (rs781811444, gnomAD 0.01%). This missense change has been observed in individual(s) with non-syndromic deafness (PMID: 27344577). ClinVar contains an entry for this variant (Variation ID: 179974). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Nov 05, 2014 | The p.Thr96Met variant in MYO7A has been identified by our laboratory in one ind ividual with sensorineural hearing loss and retinitis pigmentosa and segregated with disease in one affected relative. Both individuals carried this variant in trans with a second pathogenic variant in MYO7A. Computational prediction tools and conservation analyses suggest that the p.Thr98Met variant may impact the pro tein, though this information is not predictive enough to determine pathogenicit y. However, the presence of this variant in combination with a reported pathogen ic variant and in an individual with hearing loss and retinitis pigmentosa, incr eases the likelihood that the p.Thr96Met variant is pathogenic. In summary, alth ough additional studies are required to fully establish its clinical significanc e, this variant is likely pathogenic. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 23, 2024 | Variant summary: MYO7A c.287C>T (p.Thr96Met) results in a non-conservative amino acid change located in the Myosin head, motor domain (IPR001609) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 1.3e-05 in 230894 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.287C>T has been reported in the literature in individuals affected with hearing loss (Yan_2016). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 27344577). ClinVar contains an entry for this variant (Variation ID: 179974). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at